Professional
Added to YB: 2026-06-19
Pitch date: 2026-06-15
LNSR [bullish]
LENSAR, Inc.
+8.58%
current return
Author Info
Company Info
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally.
Market Cap
$74.8M
Pitch Price
$5.71
Price Target
11.40 (+84%)
Dividend
N/A
EV/EBITDA
-6.99
P/E
2.71
EV/Sales
1.35
Sector
Health Care Equipment and Supplies
Category
growth
LNSR: Setting Up For A New Lease On Life
LNSR: Micro-cap medical device maker of ALLY femtosecond cataract laser, launched Aug 2022. ~20% US procedure share (+5.8pp since launch), systems +4%/qtr. High-margin recurring procedure revenue drives margin expansion. New EU/Taiwan clearances. Inflected to breakeven adj EBITDA, positive FCF, no debt, ~17% mkt cap in cash. Could ~2x in 3yrs. Long. Earnings Feb 27.
Read full article (3 min)